| Title |
Bempedoic Acid for Heterozygous Familial Hypercholesterolemia: From Bench to Bedside
|
|---|---|
| Published in |
Drug Design, Development and Therapy, May 2021
|
| DOI | 10.2147/dddt.s251865 |
| Pubmed ID | |
| Authors |
Anandita Agarwala, Renato Quispe, Anne C Goldberg, Erin D Michos |
X Demographics
The data shown below were collected from the profiles of 23 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 26% |
| India | 4 | 17% |
| Finland | 1 | 4% |
| Spain | 1 | 4% |
| United Kingdom | 1 | 4% |
| Australia | 1 | 4% |
| Brazil | 1 | 4% |
| Unknown | 8 | 35% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 13 | 57% |
| Scientists | 5 | 22% |
| Science communicators (journalists, bloggers, editors) | 3 | 13% |
| Practitioners (doctors, other healthcare professionals) | 2 | 9% |
Mendeley readers
The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 28 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 3 | 11% |
| Student > Ph. D. Student | 3 | 11% |
| Student > Master | 2 | 7% |
| Student > Postgraduate | 2 | 7% |
| Researcher | 2 | 7% |
| Other | 1 | 4% |
| Unknown | 15 | 54% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 7 | 25% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 11% |
| Business, Management and Accounting | 1 | 4% |
| Energy | 1 | 4% |
| Computer Science | 1 | 4% |
| Other | 0 | 0% |
| Unknown | 15 | 54% |
Attention Score in Context
This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 February 2022.
All research outputs
#1,419,173
of 25,655,374 outputs
Outputs from Drug Design, Development and Therapy
#62
of 2,276 outputs
Outputs of similar age
#37,361
of 455,907 outputs
Outputs of similar age from Drug Design, Development and Therapy
#3
of 52 outputs
Altmetric has tracked 25,655,374 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,276 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 455,907 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.